{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:33:03Z","timestamp":1790937183125,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.molimm.2006.05.009","type":"journal-article","created":{"date-parts":[[2006,7,4]],"date-time":"2006-07-04T15:12:31Z","timestamp":1152025951000},"page":"1307-1315","source":"Crossref","is-referenced-by-count":85,"title":["The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies"],"prefix":"10.1016","volume":"44","author":[{"given":"Veronica","family":"Quintero-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor R.","family":"Ju\u00e1rez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Ort\u00edz-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourival D.","family":"Possani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Becerril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2006.05.009_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.copbio.2004.08.002","article-title":"Production technologies for monoclonal antibodies and their fragments","volume":"15","author":"Andersen","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.molimm.2006.05.009_bib2","unstructured":"Bethesda Research Laboratories. 1986. BRL pUC host: E. coli DH5\u03b1 competent cells. Focus 8:9."},{"key":"10.1016\/j.molimm.2006.05.009_bib3","series-title":"Envenomings and their Treatments","first-page":"4","article-title":"Serum therapy was discovered 100 years ago","author":"Bon","year":"1996"},{"key":"10.1016\/j.molimm.2006.05.009_bib4","series-title":"Envenomings and their Treatments","first-page":"311","article-title":"Scorpion stings and their treatment in M\u00e9xico","author":"Calder\u00f3n-Aranda","year":"1996"},{"key":"10.1016\/j.molimm.2006.05.009_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/0264-410X(95)00059-A","article-title":"The use of synthetic peptides can be a misleading approach to generate vaccines against scorpion toxins","volume":"13","author":"Calder\u00f3n-Aranda","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2006.05.009_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt0292-163","article-title":"High level Escherichia coli expression and production of a bivalent humanized antibody fragment","volume":"10","author":"Carter","year":"1992","journal-title":"Biol. Technol."},{"key":"10.1016\/j.molimm.2006.05.009_bib7","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.030527597","article-title":"Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies","volume":"97","author":"Daugherty","year":"2000","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2006.05.009_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1432-1327.2001.01923.x","article-title":"Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis Hector","volume":"268","author":"Devaux","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.molimm.2006.05.009_bib9","unstructured":"Gibson, T.J., 1984. Ph.D. Thesis. Cambridge, United Kingdom, Cambridge University."},{"key":"10.1016\/j.molimm.2006.05.009_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/protein\/gzh038","article-title":"Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37\u00b0C","volume":"17","author":"Graff","year":"2004","journal-title":"Prot. Eng. Des. Sel."},{"key":"10.1016\/j.molimm.2006.05.009_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1620\/tjem.203.295","article-title":"Characterization of a shiga toxin 1-neutralizing recombinant Fab fragment isolated by phage display system","volume":"203","author":"Inoue","year":"2004","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.molimm.2006.05.009_bib12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jmb.2004.12.060","article-title":"Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv Version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2","volume":"272","author":"Ju\u00e1rez-Gonz\u00e1lez","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2006.05.009_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jmbi.1999.3196","article-title":"Selection for improved protein stability by phage display","volume":"294","author":"Jun","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2006.05.009_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0041-0101(96)00043-8","article-title":"Fab fragments of the monoclonal antibody BCF2 are able of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann","volume":"34","author":"Licea","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2006.05.009_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jviromet.2005.03.018","article-title":"Production and characterization of recombinant human anti-Hbs antibodies","volume":"127","author":"Maeda","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.molimm.2006.05.009_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(98)01647-0","article-title":"A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis Hector","volume":"442","author":"Mousli","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molimm.2006.05.009_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1389203003381397","article-title":"Phage display of antibody fragments","volume":"1","author":"Pini","year":"2000","journal-title":"Curr. Opin. Peptide Sci."},{"key":"10.1016\/j.molimm.2006.05.009_bib18","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/j.1742-4658.2005.04687.x","article-title":"A strategy for the generation of specific human antibodies by directed evolution and phage display","volume":"272","author":"Ria\u00f1o-Umbarila","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.molimm.2006.05.009_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jmb.2005.01.053","article-title":"Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability","volume":"347","author":"R\u00f6thlisberger","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2006.05.009_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/1380-2933(95)00007-0","article-title":"In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library","volume":"1","author":"Schier","year":"1995","journal-title":"Immunotechnology"},{"key":"10.1016\/j.molimm.2006.05.009_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2003.10.015","article-title":"Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius Hoffmann","volume":"43","author":"Selisko","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2006.05.009_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jcb.20536","article-title":"Recombinant polyclonal antibodies for cancer therapy","volume":"96","author":"Sharon","year":"2005","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.molimm.2006.05.009_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.toxicon.2005.08.010","article-title":"Pharmacokinetics of a F(ab\u2032)2 scorpion antivenom in healthy human volunteers","volume":"46","author":"V\u00e1zquez","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2006.05.009_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-1759(03)00013-9","article-title":"Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles","volume":"275","author":"Weitkamp","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2006.05.009_bib25","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1021\/bi9902079","article-title":"Different equilibrium stability behavior of scFv fragments: identification, classification and improvement by protein engineering","volume":"38","author":"Worn","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2006.05.009_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1006\/jmbi.2000.4265","article-title":"Stability engineering of antibody single-chain Fv fragments","volume":"305","author":"Worn","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2006.05.009_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jmb.2005.04.049","article-title":"Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and Binding valence on viral neutralization","volume":"350","author":"Wu","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2006.05.009_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1432-1033.1992.tb16635.x","article-title":"Amino acid sequence and immunological characterization with monoclonal antibodies of two toxins from the venom of the scorpion Centruroides noxius Hoffmann","volume":"204","author":"Zamudio","year":"1992","journal-title":"Eur. J. Biochem."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589006001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589006001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T09:56:55Z","timestamp":1547546215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589006001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0161589006001969"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2006.05.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}